Karyopharm Therapeutics Inc's Comment on Supply Chain
The company faces risks of delays or infeasibility in the development, testing, clinical trials, regulatory approval, or commercial launch of product candidates due to disruptions in the global supply chain caused by macroeconomic events, including U.S. tariffs and international trade policies. Some manufacturers and suppliers, including WuXi AppTec and WuXi Biologics, are located in China, exposing the company to potential supply disruptions and increased costs resulting from escalating U.S.-China trade tensions. Certain Chinese biotechnology companies, such as WuXi AppTec and WuXi Biologics, may be subject to U.S. trade restrictions or sanctions, which could disrupt supply. Additionally, U.S. legislation enacted in December 2025 prohibits federal agencies from procuring biotechnology equipment or services from certain Chinese companies of concern, potentially affecting contracts and supply chains involving these entities.
Karyopharm Therapeutics Inc's Comment on Supply Chain
The company faces risks of delays or infeasibility in the development, testing, clinical trials, regulatory approval, or commercial launch of product candidates due to disruptions in the global supply chain caused by macroeconomic events, including U.S. tariffs and international trade policies. Some manufacturers and suppliers, including WuXi AppTec and WuXi Biologics, are located in China, exposing the company to potential supply disruptions and increased costs resulting from escalating U.S.-China trade tensions. Certain Chinese biotechnology companies, such as WuXi AppTec and WuXi Biologics, may be subject to U.S. trade restrictions or sanctions, which could disrupt supply. Additionally, U.S. legislation enacted in December 2025 prohibits federal agencies from procuring biotechnology equipment or services from certain Chinese companies of concern, potentially affecting contracts and supply chains involving these entities.
Sources:
Karyopharm Therapeutics Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Karyopharm Therapeutics Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
